Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2002 | 07-2001 | 12-2000 | 07-2000 | 12-1999 | |
| Sales | 2,596 | 3,641 | 0 | 4,113 | 0 |
| Cost of Goods | 2,241 | 1,843 | N/A | 1,905 | N/A |
| Gross Profit | 355 | 1,798 | 2,070 | 2,208 | 1,620 |
| Operating Expenses | 3,875 | 4,874 | 4,031 | 2,339 | 1,434 |
| Operating Income | -3,279 | -2,232 | -4,031 | 774 | -1,434 |
| Interest Expense | 0 | 0 | 0 | 0 | 4 |
| Other Income | -738 | -268 | 0 | 527 | 0 |
| Pre-tax Income | -4,016 | -2,501 | -4,031 | 1,301 | -1,438 |
| Net Income Continuous | -4,016 | -2,501 | 1,301 | 1,301 | 651 |
| Net Income | $-4,016 | $-2,501 | $-2,501 | $1,301 | $1,301 |
| EPS Basic Total Ops | -0.65 | -0.41 | N/A | 0.21 | N/A |
| EPS Basic Continuous Ops | -0.65 | -0.41 | N/A | 0.21 | N/A |
| EPS Diluted Total Ops | -0.65 | -0.41 | N/A | 0.21 | N/A |
| EPS Diluted Continuous Ops | -0.65 | -0.41 | N/A | 0.21 | N/A |
| EBITDA(a) | $-3,085 | $-2,018 | $-3,981 | $983 | $-1,384 |